Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  Wang, Chengguo ^a   Zhao, Huadong ^a   Lu, Jianguo ^a   Yin, Jikai ^a   Zang, Li ^a   Song, Nuan ^a   Dong, Rui ^a   Wu, Tao ^a   Du, Xilin ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Clinicopathology; Disease free survival; Overall survival; Primary gallbladder carcinoma; SOX4

Indexed keywords

SOX4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; GALLBLADDER TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SOXC TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84860869177     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-41     Document Type: Article

References (20)

1. Chen Y, Chen Y, Yu G, Ding H. Lymphangiogenic and angiogentic microvessel density in gallbladder carcinoma. Hepatogastroenterology 2011, 58:20-25.
2. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003, 4:167-176. 10.1016/S1470-2045(03)01021-0, 12623362.
3. Ahn SG, Cho GH, Jeong SY, Rhim H, Choi JY, Kim IK. Identification of cDNAs for Sox-4, an HMG-Box protein, and a novel human homolog of yeast splicing factor SSF-1 differentially regulated during apoptosis induced by prostaglandin A2/delta12-PGJ2 in Hep3B cells. Biochem Biophys Res Commun 1999, 260:216-221. 10.1006/bbrc.1999.0856, 10381369.
4. Boyd KE, Xiao YY, Fan K, Poholek A, Copeland NG, Jenkins NA, Perkins AS. Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR. Blood 2006, 107:733-741. 10.1182/blood-2003-05-1626, 1895620, 16204320.
5. Huang YW, Liu JC, Deatherage DE, Luo J, Mutch DG, Goodfellow PJ, Miller DS, Huang TH. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res 2009, 69:9038-9046. 10.1158/0008-5472.CAN-09-1499, 2789184, 19887623.
6. Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML, Moreno CS. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res 2009, 69:709-717. 10.1158/0008-5472.CAN-08-3415, 2629396, 19147588.
7. Sinner D, Kordich JJ, Spence JR, Opoka R, Rankin S, Lin SC, Jonatan D, Zorn AM, Wells JM. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol Cell Biol 2007, 27:7802-7815. 10.1128/MCB.02179-06, 2169141, 17875931.
8. Lai YH, Cheng J, Cheng D, Feasel ME, Beste KD, Peng J, Nusrat A, Moreno CS. SOX4 interacts with plakoglobin in a Wnt3a-dependent manner in prostate cancer cells. BMC Cell Biol 2011, 12:50. 10.1186/1471-2121-12-50, 3227594, 22098624.
9. Castillo SD, Matheu A, Mariani N, Carretero J, Lopez-Rios F, Lovell-Badge R, Sanchez-Cespedes M. Novel transcriptional targets of the SRY-HMG box transcription factor SOX4 link its expression to the development of small cell lung cancer. Cancer Res 2012, 72:176-186. 10.1158/0008-5472.CAN-11-3506, 22084397.
10. Andersen CL, Christensen LL, Thorsen K, Schepeler T, Srensen FB, Verspaget HW, Simon R, Kruh Ffer M, Aaltonen LA, Laurberg S. rntoft TF: Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. Br J Cancer 2009, 100:511-523. 10.1038/sj.bjc.6604884, 2658541, 19156145.
11. Gunes S, Yegin Z, Sullu Y, Buyukalpelli R, Bagci H. SOX4 expression levels in urothelial bladder carcinoma. Pathol Res Pract 2011, 207:423-427. 10.1016/j.prp.2011.05.005, 21680105.
12. Liao YL, Sun YM, Chau GY, Chau YP, Lai TC, Wang JL, Horng JT, Hsiao M, Tsou AP. Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma. Oncogene 2008, 27:5578-5589. 10.1038/onc.2008.168, 18504433.
13. Aaboe M, Birkenkamp-Demtroder K, Wiuf C, Rensen FBS, Thykjaer T, Sauter G, Jensen KM, Dyrskj TL. rntoft T: SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res 2006, 66:3434-3442. 10.1158/0008-5472.CAN-05-3456, 16585165.
14. Hur W, Rhim H, Jung CK, Kim JD, Bae SH, Jang JW, Yang JM, Oh ST, Kim DG, Wang HJ, Lee SB, Yoon SK. SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro. Carcinogenesis 2010, 31:1298-1307. 10.1093/carcin/bgq072, 20400479.
15. Shen R, Pan S, Qi S, Lin X, Cheng S. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer. Biochem Biophys Res Commun 2010, 394:1047-1052. 10.1016/j.bbrc.2010.03.121, 20331975.
16. Lee CJ, Appleby VJ, Orme AT, Chan WI, Scotting PJ. Differential expression of SOX4 and SOX11 in medulloblastoma. J Neurooncol 2002, 57:201-214. 10.1023/A:1015773818302, 12125983.
17. Cheung M, Abu-Elmagd M, Clevers H, Scotting PJ. Roles of Sox4 in central nervous system development. Brain Res Mol Brain Res 2000, 79:180-191.
18. Pan X, Zhao J, Zhang WN, Li HY, Mu R, Zhou T, Zhang HY, Gong WL, Yu M, Man JH, Zhang PJ, Li AL, Zhang XM. Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc Natl Acad Sci USA 2009, 106:3788-3793. 10.1073/pnas.0810147106, 2656158, 19234109.
19. Chen QL, Zheng WL, Yao WJ, Nie LW, Cheng SH, Ma WL. Analysis of SOX4 gene mutation in non-small cell lung cancer tissues. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2007, 24:505-509.
20. Medina PP, Castillo SD, Blanco S, Sanz-Garcia M, Largo C, Alvarez S, Yokota J, Gonzalez-Neira A, Benitez J, Clevers HC, Cigudosa JC, Lazo PA, Sanchez-Cespedes M. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer. Hum Mol Genet 2009, 18:1343-1352. 10.1093/hmg/ddp034, 19153074.